title: The influence of guaifenesin and ketoprofen on the properties of hot-melt extruded polyethylene oxide films.
abstract: Films containing polyethylene oxide (PEO) and a model drug, either guaifenesin (GFN) or ketoprofen (KTP), were prepared by hot-melt extrusion. The thermal properties of the hot-melt extruded films were investigated using differential scanning calorimetry (DSC). Scanning electron microscopy (SEM) was used to examine the surface morphology of the films, and wide angle X-ray diffraction (XRD) was used to investigate the crystalline properties of the polymer, drugs and physical mixtures as well as the solid state structure of the films. The stability of the polymer was studied using gel permeation chromatography. The mechanical properties, including percent elongation and tensile strength of the films, were determined on an Instron according to American Society for Testing Materials (ASTM) procedures. The Hansen solubility parameter was calculated using the Hoftyzer or van Krevelen method to estimate the likelihood of drug--polymer miscibility. Both GFN and KTP were stable during the extrusion process. Melting points corresponding to the crystalline drugs were not observed in the films. Crystallization of GFN on the surface of the film was observed at all concentrations studied, however KTP crystallization did not occur until reaching the 15% level. Guaifenesin and ketoprofen were found to decrease drive load, increase PEO stability and plasticize the polymer during extrusion. The Hansen solubility parameters predicted miscibility between PEO and KTP and poor miscibility between PEO and GFN. The predictions of the solubility parameters were in agreement with the XRD and SEM results. The percent elongation decreased with increasing GFN concentrations and significantly increased with increasing levels of KTP. Both GFN and KTP decreased the tensile strength of the extruded film.
authors.affiliation: Division of Pharmaceutics, College of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA. mcrowley@pharmaform.com
authors.forename: Michael M
authors.initials: MM
authors.lastname: Crowley
authors.forename: Anke
authors.initials: A
authors.lastname: Fredersdorf
authors.forename: Britta
authors.initials: B
authors.lastname: Schroeder
authors.forename: Shawn
authors.initials: S
authors.lastname: Kucera
authors.forename: Suneela
authors.initials: S
authors.lastname: Prodduturi
authors.forename: Michael A
authors.initials: MA
authors.lastname: Repka
authors.forename: James W
authors.initials: JW
authors.lastname: McGinity
mesh_terms: D004347:Drug Interactions; D006140:Guaifenesin / Q000737:chemistry* / Q000493:pharmacokinetics; D007660:Ketoprofen / Q000737:chemistry* / Q000493:pharmacokinetics; D011092:Polyethylene Glycols / Q000737:chemistry* / Q000493:pharmacokinetics
chemical_list: D011092:Polyethylene Glycols; D006140:Guaifenesin; D007660:Ketoprofen